|
시장보고서
상품코드
1067645
세계의 여드름 치료제 시장 : 인사이트와 예측(-2028년)Global Acne Medicine Market Insights, Forecast to 2028 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계의 여드름 치료제 시장 규모는 2021년 34억 9,100만 달러에서 2028년까지 44억 2,780만 달러에 이르고, 2022-2028년간 연평균 복합 성장률(CAGR) 3.4%의 성장이 예측됩니다.
세계의 여드름 치료제(Acne Medicine) 시장에 대해 조사분석했으며, 부문별 시장 분석, 매출과 예측(2017-2028년)에 초점을 맞춘 최신 정보를 제공합니다.
목차
제1장 보고서의 사업 개요
- 조사 범위
- 시장 분석 : 유형별
- 세계의 여드름 치료제 시장 규모 성장률 : 유형별
- OTC
- 처방약
- 시장 : 용도별
- 세계의 여드름 치료제 시장 규모 성장률 : 용도별
- 국소
- 경구
- 조사 목적
- 대상년도
제2장 세계의 성장 동향
- 세계의 여드름 치료제 시장 전망
- 여드름 치료제 성장 동향 : 지역별
- 여드름 치료제 시장 역학
- 여드름 치료제 업계 동향
- 여드름 치료제 시장 성장 촉진요인
- 여드름 치료제 시장이 해결해야 할 과제
- 여드름 치료제 시장 성장 억제요인
제3장 경쟁 구도 : 주요 기업별
- 세계의 여드름 치료제 주요 기업 : 매출별
- 세계의 여드름 치료제 시장 점유율 : 기업 유형별(Tier 1, Tier 2, Tier 3)
- 대상 기업 - 순위 : 여드름 치료제 매출별
- 세계의 여드름 치료제 시장 집중도
- 여드름 치료제 주요 기업의 본사와 제공 지역
- 여드름 치료제 주요 기업의 제품 솔루션과 서비스
- 여드름 치료제 시장 진출일
- 인수합병(M&A) 및 확장 계획
제4장 여드름 치료제 분석 데이터 : 유형별
- 세계의 여드름 치료제 과거 시장 규모 : 유형별
- 세계의 여드름 치료제 시장 규모 예측 : 유형별
제5장 여드름 치료제 분석 데이터 : 용도별
- 세계의 여드름 치료제 과거 시장 규모 : 용도별
- 세계의 여드름 치료제 시장 규모 예측 : 용도별
제6장 북미
- 북미의 여드름 치료제 시장 규모
- 북미의 여드름 치료제 시장 규모 : 유형별
- 북미의 여드름 치료제 시장 규모 : 용도별
- 북미의 여드름 치료제 시장 규모 : 국가별
- 미국
- 캐나다
제7장 유럽
- 유럽의 여드름 치료제 시장 규모
- 유럽의 여드름 치료제 시장 규모 : 유형별
- 유럽의 여드름 치료제 시장 규모 : 용도별
- 유럽의 여드름 치료제 시장 규모 : 국가별
- 독일
- 프랑스
- 영국
- 이탈리아
- 러시아
- 북유럽 국가
제8장 아시아태평양
- 아시아태평양의 여드름 치료제 시장 규모
- 아시아태평양의 여드름 치료제 시장 규모 : 유형별
- 아시아태평양의 여드름 치료제 시장 규모 : 용도별
- 아시아태평양의 여드름 치료제 시장 규모 : 지역별
- 중국
- 일본
- 한국
- 동남아시아
- 인도
- 호주
제9장 라틴아메리카
- 라틴아메리카의 여드름 치료제 시장 규모
- 라틴아메리카의 여드름 치료제 시장 규모 : 유형별
- 라틴아메리카의 여드름 치료제 시장 규모 : 용도별
- 라틴아메리카의 여드름 치료제 시장 규모 : 국가별
- 멕시코
- 브라질
제10장 중동 및 아프리카
- 중동 및 아프리카의 여드름 치료제 시장 규모
- 중동 및 아프리카의 여드름 치료제 시장 규모 : 유형별
- 중동 및 아프리카의 여드름 치료제 시장 규모 : 용도별
- 중동 및 아프리카의 여드름 치료제 시장 규모 : 국가별
- 터키
- 사우디아라비아
- 아랍에미리트(UAE)
제11장 주요 기업 개요
- Galderma
- Bausch Health
- Teva
- GlaxoSmithKline
- Mylan
- Almirall
- Sun Pharma
- Mayne Pharma
- Lion
- HUAPONT
- Sine Pharma
제12장 애널리스트의 견해/결론
제13장 부록
LSH 22.04.11Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high number of oil glands, including the face, upper part of the chest, and back. The resulting appearance can lead to anxiety, reduced self-esteem, and, in extreme cases, depression or thoughts of suicide.
Market Analysis and Insights: Global Acne Medicine Market
The global Acne Medicine market size is projected to reach US$ 4427.8 million by 2028, from US$ 3491 million in 2021, at a CAGR of 3.4% during 2022-2028.
Global core acne medicine manufacturers include Galderma, Bausch Health, Teva etc.The top 3 companies hold a share about 50%. North America is the largest market, with a share about 50%, followed by Europe and Asia Pacific with the share about 25% and 15%.In terms of product, prescription medicine is the largest segment, with a share over 77%. And in terms of application, the largest application is topical, followed by oral.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acne Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acne Medicine market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acne Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acne Medicine market.
Global Acne Medicine Scope and Market Size
Acne Medicine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Acne Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- OTC
- Prescription Medicine
Segment by Application
- Topical
- Oral
By Company
- Galderma
- Bausch Health
- Teva
- GlaxoSmithKline
- Mylan
- Almirall
- Sun Pharma
- Mayne Pharma
- Lion
- HUAPONT
- Sine Pharma
By Region
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Acne Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 OTC
- 1.2.3 Prescription Medicine
- 1.3 Market by Application
- 1.3.1 Global Acne Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Topical
- 1.3.3 Oral
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Acne Medicine Market Perspective (2017-2028)
- 2.2 Acne Medicine Growth Trends by Region
- 2.2.1 Acne Medicine Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Acne Medicine Historic Market Size by Region (2017-2022)
- 2.2.3 Acne Medicine Forecasted Market Size by Region (2023-2028)
- 2.3 Acne Medicine Market Dynamics
- 2.3.1 Acne Medicine Industry Trends
- 2.3.2 Acne Medicine Market Drivers
- 2.3.3 Acne Medicine Market Challenges
- 2.3.4 Acne Medicine Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Acne Medicine Players by Revenue
- 3.1.1 Global Top Acne Medicine Players by Revenue (2017-2022)
- 3.1.2 Global Acne Medicine Revenue Market Share by Players (2017-2022)
- 3.2 Global Acne Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Acne Medicine Revenue
- 3.4 Global Acne Medicine Market Concentration Ratio
- 3.4.1 Global Acne Medicine Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Acne Medicine Revenue in 2021
- 3.5 Acne Medicine Key Players Head office and Area Served
- 3.6 Key Players Acne Medicine Product Solution and Service
- 3.7 Date of Enter into Acne Medicine Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Acne Medicine Breakdown Data by Type
- 4.1 Global Acne Medicine Historic Market Size by Type (2017-2022)
- 4.2 Global Acne Medicine Forecasted Market Size by Type (2023-2028)
5 Acne Medicine Breakdown Data by Application
- 5.1 Global Acne Medicine Historic Market Size by Application (2017-2022)
- 5.2 Global Acne Medicine Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Acne Medicine Market Size (2017-2028)
- 6.2 North America Acne Medicine Market Size by Type
- 6.2.1 North America Acne Medicine Market Size by Type (2017-2022)
- 6.2.2 North America Acne Medicine Market Size by Type (2023-2028)
- 6.2.3 North America Acne Medicine Market Share by Type (2017-2028)
- 6.3 North America Acne Medicine Market Size by Application
- 6.3.1 North America Acne Medicine Market Size by Application (2017-2022)
- 6.3.2 North America Acne Medicine Market Size by Application (2023-2028)
- 6.3.3 North America Acne Medicine Market Share by Application (2017-2028)
- 6.4 North America Acne Medicine Market Size by Country
- 6.4.1 North America Acne Medicine Market Size by Country (2017-2022)
- 6.4.2 North America Acne Medicine Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Acne Medicine Market Size (2017-2028)
- 7.2 Europe Acne Medicine Market Size by Type
- 7.2.1 Europe Acne Medicine Market Size by Type (2017-2022)
- 7.2.2 Europe Acne Medicine Market Size by Type (2023-2028)
- 7.2.3 Europe Acne Medicine Market Share by Type (2017-2028)
- 7.3 Europe Acne Medicine Market Size by Application
- 7.3.1 Europe Acne Medicine Market Size by Application (2017-2022)
- 7.3.2 Europe Acne Medicine Market Size by Application (2023-2028)
- 7.3.3 Europe Acne Medicine Market Share by Application (2017-2028)
- 7.4 Europe Acne Medicine Market Size by Country
- 7.4.1 Europe Acne Medicine Market Size by Country (2017-2022)
- 7.4.2 Europe Acne Medicine Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Acne Medicine Market Size (2017-2028)
- 8.2 Asia-Pacific Acne Medicine Market Size by Type
- 8.2.1 Asia-Pacific Acne Medicine Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Acne Medicine Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Acne Medicine Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Acne Medicine Market Size by Application
- 8.3.1 Asia-Pacific Acne Medicine Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Acne Medicine Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Acne Medicine Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Acne Medicine Market Size by Region
- 8.4.1 Asia-Pacific Acne Medicine Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Acne Medicine Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Acne Medicine Market Size (2017-2028)
- 9.2 Latin America Acne Medicine Market Size by Type
- 9.2.1 Latin America Acne Medicine Market Size by Type (2017-2022)
- 9.2.2 Latin America Acne Medicine Market Size by Type (2023-2028)
- 9.2.3 Latin America Acne Medicine Market Share by Type (2017-2028)
- 9.3 Latin America Acne Medicine Market Size by Application
- 9.3.1 Latin America Acne Medicine Market Size by Application (2017-2022)
- 9.3.2 Latin America Acne Medicine Market Size by Application (2023-2028)
- 9.3.3 Latin America Acne Medicine Market Share by Application (2017-2028)
- 9.4 Latin America Acne Medicine Market Size by Country
- 9.4.1 Latin America Acne Medicine Market Size by Country (2017-2022)
- 9.4.2 Latin America Acne Medicine Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Acne Medicine Market Size (2017-2028)
- 10.2 Middle East & Africa Acne Medicine Market Size by Type
- 10.2.1 Middle East & Africa Acne Medicine Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Acne Medicine Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Acne Medicine Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Acne Medicine Market Size by Application
- 10.3.1 Middle East & Africa Acne Medicine Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Acne Medicine Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Acne Medicine Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Acne Medicine Market Size by Country
- 10.4.1 Middle East & Africa Acne Medicine Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Acne Medicine Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Galderma
- 11.1.1 Galderma Company Details
- 11.1.2 Galderma Business Overview
- 11.1.3 Galderma Acne Medicine Introduction
- 11.1.4 Galderma Revenue in Acne Medicine Business (2017-2022)
- 11.1.5 Galderma Recent Developments
- 11.2 Bausch Health
- 11.2.1 Bausch Health Company Details
- 11.2.2 Bausch Health Business Overview
- 11.2.3 Bausch Health Acne Medicine Introduction
- 11.2.4 Bausch Health Revenue in Acne Medicine Business (2017-2022)
- 11.2.5 Bausch Health Recent Developments
- 11.3 Teva
- 11.3.1 Teva Company Details
- 11.3.2 Teva Business Overview
- 11.3.3 Teva Acne Medicine Introduction
- 11.3.4 Teva Revenue in Acne Medicine Business (2017-2022)
- 11.3.5 Teva Recent Developments
- 11.4 GlaxoSmithKline
- 11.4.1 GlaxoSmithKline Company Details
- 11.4.2 GlaxoSmithKline Business Overview
- 11.4.3 GlaxoSmithKline Acne Medicine Introduction
- 11.4.4 GlaxoSmithKline Revenue in Acne Medicine Business (2017-2022)
- 11.4.5 GlaxoSmithKline Recent Developments
- 11.5 Mylan
- 11.5.1 Mylan Company Details
- 11.5.2 Mylan Business Overview
- 11.5.3 Mylan Acne Medicine Introduction
- 11.5.4 Mylan Revenue in Acne Medicine Business (2017-2022)
- 11.5.5 Mylan Recent Developments
- 11.6 Almirall
- 11.6.1 Almirall Company Details
- 11.6.2 Almirall Business Overview
- 11.6.3 Almirall Acne Medicine Introduction
- 11.6.4 Almirall Revenue in Acne Medicine Business (2017-2022)
- 11.6.5 Almirall Recent Developments
- 11.7 Sun Pharma
- 11.7.1 Sun Pharma Company Details
- 11.7.2 Sun Pharma Business Overview
- 11.7.3 Sun Pharma Acne Medicine Introduction
- 11.7.4 Sun Pharma Revenue in Acne Medicine Business (2017-2022)
- 11.7.5 Sun Pharma Recent Developments
- 11.8 Mayne Pharma
- 11.8.1 Mayne Pharma Company Details
- 11.8.2 Mayne Pharma Business Overview
- 11.8.3 Mayne Pharma Acne Medicine Introduction
- 11.8.4 Mayne Pharma Revenue in Acne Medicine Business (2017-2022)
- 11.8.5 Mayne Pharma Recent Developments
- 11.9 Lion
- 11.9.1 Lion Company Details
- 11.9.2 Lion Business Overview
- 11.9.3 Lion Acne Medicine Introduction
- 11.9.4 Lion Revenue in Acne Medicine Business (2017-2022)
- 11.9.5 Lion Recent Developments
- 11.10 HUAPONT
- 11.10.1 HUAPONT Company Details
- 11.10.2 HUAPONT Business Overview
- 11.10.3 HUAPONT Acne Medicine Introduction
- 11.10.4 HUAPONT Revenue in Acne Medicine Business (2017-2022)
- 11.10.5 HUAPONT Recent Developments
- 11.11 Sine Pharma
- 11.11.1 Sine Pharma Company Details
- 11.11.2 Sine Pharma Business Overview
- 11.11.3 Sine Pharma Acne Medicine Introduction
- 11.11.4 Sine Pharma Revenue in Acne Medicine Business (2017-2022)
- 11.11.5 Sine Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer
비교리스트